학술논문

Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trial
Document Type
Article
Source
In: Journal of Allergy and Clinical Immunology. (Journal of Allergy and Clinical Immunology, September 2021, 148(3):783-789)
Subject
Language
English
ISSN
10976825
00916749